InChI=1S/C41H64O13/c1- 20- 36(46) 29(42) 16- 34(49- 20) 53- 38- 22(3) 51- 35(18- 31(38) 44) 54- 37- 21(2) 50- 33(17- 30(37) 43) 52- 25- 8- 11- 39(4) 24(15- 25) 6- 7- 28- 27(39) 9- 12- 40(5) 26(10- 13- 41(28,40) 47) 23- 14- 32(45) 48- 19- 23/h14,20- 22,24- 31,33- 38,42- 44,46- 47H,6- 13,15- 19H2,1- 5H3/t20- ,21- ,22- ,24- ,25+,26- ,27+,28- ,29+,30+,31+,33+,34+,35+,36- ,37- ,38- ,39+,40- ,41+/m1/s1 |
WDJUZGPOPHTGOT-XUDUSOBPSA-N |
[H] [C@] 12CC[C@] 3([H] ) [C@] ([H] ) (CC[C@] 4(C) [C@] ([H] ) (CC[C@] 34O) C3=CC(=O) OC3) [C@@] 1(C) CC[C@@H] (C2) O[C@H] 1C[C@H] (O) [C@H] (O[C@H] 2C[C@H] (O) [C@H] (O[C@H] 3C[C@H] (O) [C@H] (O) [C@@H] (C) O3) [C@@H] (C) O2) [C@@H] (C) O1 |
|
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Na+/K+-transporting ATPase (EC 3.6.3.9).
|
|
cardioprotective agent
Any protective agent that is able to prevent damage to the heart.
(via cardiac glycoside )
|
|
View more via ChEBI Ontology
3β- [2,6- dideoxy- β- D- ribo- hexopyranosyl- (1→4)- 2,6- dideoxy- β- D- ribo- hexopyranosyl- (1→4)- 2,6- dideoxy- β- D- ribo- hexopyranosyloxy]- 14- hydroxy- 5β- card- 20(22)- enolide
|
Crystodigin (TN)
|
KEGG DRUG
|
Digitoxin
|
KEGG COMPOUND
|
Digitoxoside
|
ChemIDplus
|
881
|
DrugCentral
|
C00003617
|
KNApSAcK
|
C06955
|
KEGG COMPOUND
|
D00297
|
KEGG DRUG
|
DB01396
|
DrugBank
|
Digitoxin
|
Wikipedia
|
View more database links |
71-63-6
|
CAS Registry Number
|
KEGG COMPOUND
|
71-63-6
|
CAS Registry Number
|
ChemIDplus
|
76678
|
Reaxys Registry Number
|
Reaxys
|
10438974
|
PubMed citation
|
Europe PMC
|
10687899
|
PubMed citation
|
Europe PMC
|
26573786
|
PubMed citation
|
Europe PMC
|
|